Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | CD86 |
| Upstream (Parents) |
|---|
| (<<) IFI30 → CD86 |
| (<<) SRGN → CD86 |
| (<<) FPR3 → CD86 |
| (<<) LAPTM5 → CD86 |
| (<<) TYROBP → CD86 |
| Downstream (Children) |
|---|
| CD86 → NCF2 (>>) |
| CD86 → IFI30 (>>) |
| CD86 → HLA-DQA2///HLA-DQA1 (>>) |
| CD86 → CLEC7A (>>) |
| CD86 → SRGN (>>) |
| CD86 → MS4A4A (>>) |
| CD86 → CTSS (>>) |
| CD86 → FPR3 (>>) |
| CD86 → FCGR1B (>>) |
| CD86 → TMEM176B (>>) |
| CD86 → FCGR1C///FCGR1A (>>) |
| CD86 → LAPTM5 (>>) |
| CD86 → TYROBP (>>) |
| CD86 → ARL11 (>>) |
| CD86 → CHST11 (>>) |
| CD86 → PILRA (>>) |
| CD86 → SAT1 (>>) |
| CD86 → LY96 (>>) |
